Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Hydroxyammonium chloride

Base Information Edit
  • Chemical Name:Hydroxyammonium chloride
  • CAS No.:5470-11-1
  • Deprecated CAS:379722-73-3
  • Molecular Formula:H3NO.HCl
  • Molecular Weight:69.4909
  • Hs Code.:28251000
  • DSSTox Substance ID:DTXSID7025425
  • Wikidata:Q421356
  • Mol file:5470-11-1.mol
Hydroxyammonium chloride

Synonyms:Hydroxyammonium chloride;DTXSID7025425;(N H3 (O H)) Cl;hydroxylammoniumchlorid;H4ClNO;Hydroxylaminhydrochlorid;Hydroxylammoniumchloride;hydoxylammonium chloride;hydroxy ammonium chloride;hydroxy-ammonium chloride;hydroxyl-ammonium chloride;UNII-5X4ZA62Z4Q;WCYJQVALWQMJGE-UHFFFAOYSA-M;hydroxyazanium chloride, AldrichCPR;Tox21_202970;AKOS024256075;NCGC00260516-01;CAS-5470-11-1;EC 226-798-2;Q421356

Suppliers and Price of Hydroxyammonium chloride
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • Hydroxylamine Hydrochloride
  • 5g
  • $ 45.00
  • TCI Chemical
  • Hydroxylamine Hydrochloride >97.0%(T)
  • 500g
  • $ 65.00
  • TCI Chemical
  • Hydroxylamine Hydrochloride >97.0%(T)
  • 25g
  • $ 13.00
  • SynQuest Laboratories
  • Hydroxylamine hydrochloride 99%
  • 25 g
  • $ 15.00
  • SynQuest Laboratories
  • Hydroxylamine hydrochloride 99%
  • 100 g
  • $ 40.00
  • SynQuest Laboratories
  • Hydroxylamine hydrochloride 99%
  • 5 g
  • $ 10.00
  • Sigma-Aldrich
  • Hydroxylamine hydrochloride
  • 1
  • $ 323.00
  • Sigma-Aldrich
  • Hydroxylamine hydrochloride 99.999% trace metals basis
  • 250g
  • $ 319.00
  • Sigma-Aldrich
  • Hydroxylamine Hydrochloride Meets ACS Specifications, Meets Reagent Specifications for testing USP/NF monographs GR ACS
  • 500 g
  • $ 308.02
  • Sigma-Aldrich
  • Hydroxylammonium chloride for analysis (≤ 0.000001% Hg) ACS,ISO
  • 250 g
  • $ 306.17
Total 248 raw suppliers
Chemical Property of Hydroxyammonium chloride Edit
Chemical Property:
  • Appearance/Colour:Colorless or off-white crystalline solid 
  • Vapor Pressure:179mmHg at 25°C 
  • Melting Point:155-158 °C 
  • Boiling Point:56.5 °C at 760 mmHg 
  • PSA:46.25000 
  • Density:1.67 g/mL at 25 °C 
  • LogP:0.83660 
  • Storage Temp.:Store at RT. 
  • Sensitive.:Hygroscopic 
  • Solubility.:470g/l 
  • Water Solubility.:560 g/L (20 ºC) 
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:2
  • Rotatable Bond Count:0
  • Exact Mass:68.9981414
  • Heavy Atom Count:3
  • Complexity:2
Purity/Quality:

99%min. *data from raw suppliers

Hydroxylamine Hydrochloride *data from reagent suppliers

Safty Information:
  • Pictogram(s): HarmfulXn, Dangerous
  • Hazard Codes:Xn,N,E 
  • Statements: 22-36/38-43-48/22-50-40-21/22-2 
  • Safety Statements: 22-24-37-61-36/37 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Canonical SMILES:[NH3+]O.[Cl-]
  • General Description Hydroxylamine hydrochloride is a versatile reagent used in various chemical syntheses, including the formation of hydroxymetanimidoyl groups, heterocyclic compounds, and oximes. It plays a key role in nucleophilic reactions, reductive condensations, and the synthesis of bioactive molecules such as acetylcholinesterase inhibitors and antitubercular agents. Its applications span pharmaceuticals, materials science, and organic chemistry, demonstrating its utility in producing high-yield, enantioselective, and non-toxic compounds.
Technology Process of Hydroxyammonium chloride

There total 49 articles about Hydroxyammonium chloride which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With hydrogenchloride; In methanol; byproducts: NH4Cl, N2H5Cl; (N2); HCl bubbled through a soln. of the Mo-complex at 0°C for 15 min; soln. stirred for 1.5 h at room temp.; N2 bubbled through the suspn. for 15 min; ppt. filtered, washed with methanol and diethyl ether; recrystd. from hot THF;
Guidance literature:
With hydrogenchloride; In hydrogenchloride; byproducts: C2H5OH, H2O; in concd. HCl soln.; evapn. of the alcohol,diluting with water,pptg. of the Sn with H2S,evapn. and crystn. from alcohol;
Guidance literature:
In methanol; stirring the soln. for 30 min between room temp. and 60°C, pptn.; filtration, washing with water, recrystn. from acetone;
DOI:10.1016/S0020-1693(00)83239-9
Refernces Edit

Synthesis and spectroscopic properties of Ni(II) complexes of some aroyl hydrazone ligands with 2,6-diacetyl pyridine monooxime: X-ray crystal structure of the salicyloylhydrazone Ni(II) complex

10.1016/j.ica.2010.05.009

The study focuses on the synthesis and characterization of five new Ni(II) complexes with aroyl hydrazone ligands derived from 2,6-diacetyl pyridine monooxime. The complexes were found to have a distorted octahedral N4O2 coordination environment around the Ni(II) ion, with the ligands coordinating through the pyridine nitrogen, imino-hydrazone nitrogen, and the deprotonated oxygen of the hydrazone moiety. The uncoordinated iminooxime groups and the orthogonal orientation of the CH3–C@N–OH groups relative to the adjacent pyridine rings were observed. The ligands and their corresponding Ni(II) complexes exhibited luminescence, with the complexes showing a lower quantum yield compared to the free ligands. The study also includes the X-ray crystal structure of the Ni(II) salicyloylhydrazone complex, which revealed details about the molecular structure and hydrogen bonding interactions in the crystal lattice. The research provides insights into the coordination chemistry of aroyl hydrazone ligands and their potential applications in areas such as pharmaceuticals and materials science.

Organocatalytic enantioselective formal conjugate addition of a hydroxymoyl anion to α,β-unsaturated aldehydes

10.1002/chem.201100605

The research focuses on the development of an organocatalytic enantioselective formal conjugate addition of a hydroxymoyl anion to α,β-unsaturated aldehydes, which is a significant transformation in organic chemistry. The study explores the use of N-nitromethylphthalimide as a hydroxymetanimidoyl anion equivalent in enantioselective conjugate addition reactions under iminium activation, using a chiral secondary amine as the organocatalyst. The experiments involved the optimization of reaction conditions and the identification of the best catalyst for the initial conjugate addition of N-nitromethylphthalimide to α,β-unsaturated aldehydes. The reaction was found to be efficient with O-TMS diphenyl prolinol as the catalyst and EtOH as the solvent at 4°C, yielding a variety of Michael addition products with good yields and excellent enantioselectivities. Further experiments included the transformation of the nitro(phthalimido)methyl moiety into the hydroxymetanimidoyl group, which was achieved through a series of steps involving protection of the formyl moiety, reaction with hydroxylamine hydrochloride, and ozonolysis to obtain chiral aldehydes. The analyses used to determine the success of the reactions included NMR spectroscopic analysis for diastereoisomeric ratios, HPLC on chiral stationary phase for enantiomeric excess (ee), and chemical correlation for assigning the absolute configuration of the stereocenter.

Formation of reagent-selective products from 2-(4,5-dihydrothi- azol-2-ylthio)-1-arylethanone with different nucleophiles

10.1080/17415993.2010.533772

The study investigates the reactions of 2-(4,5-dihydrothiazol-2-ylthio)-1-arylethanone with various nucleophiles, including semicarbazide hydrochloride, hydroxylamine hydrochloride, hydrazine, ethylenediamine, and aminoethanol, to form a range of products selective to the reagents used. The purpose of these reactions is to synthesize heterocyclic compounds containing selenium and sulfur, which are of interest due to their potential applications in the preparation of alkynes and their pharmacological properties, such as antifungal and antibacterial activities. The study explores the formation of different products with different nucleophiles, highlighting the selective nature of the reactions and the resulting compounds' structures, which were confirmed through techniques like single-crystal X-ray analysis.

Facile synthesis of oxo-/thioxopyrimidines and tetrazoles C-C linked to sugars as novel non-toxic antioxidant acetylcholinesterase inhibitors

10.1016/j.carres.2011.11.006

The research aims to synthesize novel compounds that are linked to sugars and possess both antioxidant properties and the ability to inhibit acetylcholinesterase, an enzyme associated with Alzheimer's disease. The study compares the efficiency of conventional heating methods with microwave-assisted synthesis for the creation of these compounds, which include oxo-/thioxopyrimidines and tetrazoles linked to furanoses with D-xylo and D-ribo configurations, and to a D-galacto pyranose. The chemicals used in the synthesis process involve dialdofuranoses and dialdopyranoses, β-keto esters, urea or thiourea, hydroxylamine hydrochloride, copper sulfate, triethylamine, dicyclohexylcarbodiimide, and sodium azide. The research concludes that microwave irradiation is a more efficient method, yielding the target molecules in high yield and in a significantly shorter time (10 minutes) compared to conventional heating. The synthesized compounds showed acetylcholinesterase inhibition ranging from 20% to 80% at a concentration of 100 μg/mL and exhibited antioxidant activity in the β-carotene/linoleic acid assay, with some compounds showing IC50 values comparable to gallic acid. Importantly, the bioactive compounds did not exhibit cytotoxic effects on human lymphocytes nor genotoxicity, indicating their potential as non-toxic therapeutic agents for the control of Alzheimer's disease symptoms.

Reactivity of bis(arylcarbamoyl)-N-arylphenacylamine oximes. Synthesis of 1,3-dihydroimidazol-2-ones and N-unsubstituted O- arylcarbamoylhydroxylamines

10.1016/S0040-4020(98)01046-1

The research involves the synthesis and reactivity of bis(arylcarbamoyl)-N-arylphenacylamine oximes, which are precursors to N-unsubstituted O-arylcarbamoylhydroxylamines and 1,3-dihydroimidazol-2-ones. The study aimed to explore the Beckmann fragmentation and intramolecular cyclization of these compounds to form imidazol-2-ones. The researchers found that the expected Beckmann fragmentation did not occur under the tested conditions, and instead, the compounds underwent intramolecular nucleophilic addition, leading to the formation of imidazolidinones. The synthesis involved the use of N-arylphenacylamines, hydroxylamine hydrochloride, sodium acetate, aryl isocyanates, and TsOH.H2O (p-toluenesulfonic acid monohydrate), among other reagents. The conclusions of the research were that bis(arylcarbamoyl)-N-arylphenacylamine oximes are excellent precursors for the synthesis of the target compounds, and the reactions provided high yields of the desired products, with the process being confirmed through various analytical techniques including NMR, IR, and mass spectrometry.

A simple and efficient synthesis of new mono- and bis([1,2,4]-oxadiazol)- benzaldehyde building blocks

10.1055/s-2007-990834

The research focuses on the development of a simple and efficient method for synthesizing new mono- and bis([1,2,4]-oxadiazol)benzaldehyde building blocks, which are valuable in organic chemistry for a variety of applications. The purpose of this study was to create a high-yielding, five-step procedure with minimal and straightforward purifications, starting from readily available benzamidoxime, derived from 4-cyanobenzaldehyde. The conclusion of the research is that the team successfully developed a general method for synthesizing these compounds with aromatic and aliphatic linkers, yielding overall yields between 66% and 80%. Key chemicals used in the process include 4-cyanobenzaldehyde, ethylene glycol, p-toluenesulfonic acid, hydroxylamine hydrochloride, sodium carbonate, pyridine, phenylacetyl chloride, and various dicarboxylic acids or acid dichlorides to introduce different linkers. The final products, the mono- and bis([1,2,4]-oxadiazol)benzaldehydes, were obtained through a series of reactions involving O-acylation, acetal deprotection, and cyclization steps.

Initial steps in the reductive condensation of trichloromethylarenes with hydroxylamine and hydrazines in pyridine

10.1007/BF00699000

The research investigates the initial steps of the reductive condensation of trichloromethylarenes with hydroxylamine or hydrazines in pyridine. The purpose is to understand the role of pyridine in these reactions and the initial steps of the reductive condensation process. The key chemicals used include trichloromethylarenes, hydroxylamine hydrochloride, hydrazine salts, and pyridine. The study found that pyridine may act as the actual reducing agent, undergoing oxidation to form N-(4-pyridyl)pyridinium salts, which then react with hydrazine to produce 4-pyridylhydrazine. This compound further reacts to form unusual products like 4-pyridylhydrazones of substituted benzaldehydes. The research concludes that pyridine plays a more complex role than previously thought, contributing significantly to the high yields of certain products even at equimolar ratios of reactants. In the research, hydroxylamine hydrochloride plays a crucial role as a reagent in the reductive condensation process. 4-pyridylhydrazine is identified as an unexpected and significant product formed during the reductive condensation process involving pyridine.

N-Hydroxythiosemicarbazones: Synthesis and in vitro antitubercular activity

10.1016/j.bmcl.2007.01.037

The research aimed to develop new antimicrobial drugs with potent anti-tuberculosis activity due to the urgent need for more effective treatments against multidrug-resistant tuberculosis (MDR-TB). The study focused on synthesizing N-hydroxythiosemicarbazide and its derivatives, which were then tested for their in vitro activity against Mycobacterium tuberculosis H37Rv. The synthesis involved starting materials like 2,4-dimethoxy benzyl amine and hydroxylamine hydrochloride, and various aldehydes and ketones to obtain the titled compounds. The most potent compound, (4-bromophenyl)(phenyl)methanone N-hydroxythiosemicarbazone (10p), showed an MIC of 0.28 μM and was 2.5 times more active than the standard drug isoniazid. The study concluded that the synthesized compounds, particularly compound 10p, due to their potency, selectivity, and low cytotoxicity, are valid leads for further development of new compounds with better activity against tuberculosis.

Post RFQ for Price